Free Trial

Cidara Therapeutics (CDTX) Earnings Date, Estimates & Call Transcripts

Cidara Therapeutics logo
$15.12 -0.51 (-3.26%)
(As of 11/20/2024 ET)

Cidara Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Apr. 28Estimated
Actual EPS
(Aug. 13)
-$2.05 Beat By $1.89
Consensus EPS
(Aug. 13)
-$3.94

Cidara Therapeutics announced Q2 2024 earnings on August 13, 2024, reporting an EPS of -$2.05, which topped the consensus estimate of -$3.94 by $1.89. Quarterly revenue was reported to be $0.30 million. With a trailing EPS of -$25.52, Cidara Therapeutics' earnings are expected to decrease next year, from ($8.74) to ($14.39) per share.

CDTX Upcoming Earnings

Cidara Therapeutics' next earnings date is estimated for Monday, April 28, 2025, based off prior year's reporting schedules.

Get Cidara Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cidara Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CDTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CDTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cidara Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$1.50-$1.50-$1.50
Q2 20241-$3.94-$3.94-$3.94
Q3 20241-$5.22-$5.22-$5.22
Q4 20241-$5.28-$5.28-$5.28
FY 20244-$15.94-$15.94-$15.94
Q1 20251-$5.13-$5.13-$5.13
Q2 20251-$4.96-$4.96-$4.96
Q3 20251-$4.27-$4.27-$4.27
Q4 20251-$1.81-$1.81-$1.81
FY 20254($16.17)($16.17)($16.17)

Cidara Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
4/28/2025
(Estimated)
------- 
8/13/2024Q2 2024-$3.94-$2.05+$1.89$15.89-$0.30M
5/15/2024Q1 2024-$1.50-$2.28 -$0.78-$2.28$14.50M$8.46M
4/22/2024Q4 2023--$0.80 -$0.80-$0.80-$17.58M
11/2/2023Q3 2023-$2.80-$1.80+$1.00-$0.09$8.02M$12.72M
8/3/2023Q2 2023-$1.60-$2.80 -$1.20-$0.14$14.34M$7.61M
5/11/2023Q1 2023$1.20$0.60 -$0.60$0.03$23.75M$25.99M
3/23/2023Q4 2022-$0.20-$3.80 -$3.60-$0.19$18.60M$10.22M

Cidara Therapeutics Earnings - Frequently Asked Questions

Cidara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 28th, 2025 based off last year's report dates. Learn more on CDTX's earnings history.

In the previous quarter, Cidara Therapeutics (NASDAQ:CDTX) reported ($2.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.94) by $1.89. Learn more on analysts' earnings estimate vs. CDTX's actual earnings.

Cidara Therapeutics (NASDAQ:CDTX) has a recorded annual revenue of $63.90 million.

Cidara Therapeutics (NASDAQ:CDTX) has a recorded net income of -$22.93 million. CDTX has generated -$25.52 earnings per share over the last four quarters.

Cidara Therapeutics's earnings are expected to decrease from ($8.74) per share to ($14.39) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CDTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners